Immutep (ASX: IMM, NASDAQ: IMMP) continues to advance its immuno-oncology and autoimmune pipeline, with its lead candidate eftilagimod alpha (efti) showing encouraging results in clinical trials for ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) has reported positive Phase 2 trial results for ATH434, its lead candidate for ...

Nico Resources (ASX: NC1) continues to advance its flagship Wingellina Nickel-Cobalt Project, a key asset in the Central ...

Surefire Resources (ASX: SRN) has reported improved grades from metallurgical test work at its Victory Bore Critical Minerals ...

Neuren Pharmaceuticals (ASX: NEU) has announced that the US Food and Drug Administration (FDA) has granted Fast Track ...

TALi Digital Limited (ASX: TD1) has reported a 90.9% reduction in losses, posting a half-year loss of $263,945 for the six ...

Narryer Metals (ASX: NYM) has reported further high-grade titanium mineralisation from drilling at the Muckanippie Titanium ...

National Australia Bank (ASX: NAB) has reported a solid first-quarter performance for the 2025 financial year, with 2% growth ...

Markets are watching closely as US and Russian officials meet for the first time in years to discuss a possible resolution to ...

Santos (ASX: STO) has reported strong financial results for 2024, with net profit after tax of US$1.2 billion and free cash ...

Flynn Gold (ASX: FG1) has reported high-grade silver-lead-zinc mineralisation from rock chip sampling at its Henty Project in ...

Horizon Oil Limited (ASX: HZN) has successfully completed drilling and casing of the WM30 development well at the Mereenie ...